Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization TVTX - Travere Therapeutics, Inc.
38.5 M
LAST VALUE
20.32%
2 YEAR CAGR
15.60%
5 YEAR CAGR
67.93%
10 YEAR CAGR